Table:
begin	end	state
1	5	non-cytoplasmic
6	24	transmembrane
25	34	cytoplasmic
35	59	transmembrane
60	64	non-cytoplasmic
65	83	transmembrane
84	103	cytoplasmic
104	135	transmembrane
136	140	non-cytoplasmic
141	168	transmembrane
169	177	cytoplasmic
178	196	transmembrane
197	203	non-cytoplasmic
204	226	transmembrane
227	237	cytoplasmic
238	258	transmembrane
259	263	non-cytoplasmic
264	281	transmembrane
282	325	cytoplasmic
326	343	transmembrane
344	372	non-cytoplasmic
373	391	transmembrane
392	409	cytoplasmic
410	427	transmembrane
428	446	non-cytoplasmic
447	471	transmembrane
472	499	cytoplasmic
500	530	transmembrane
531	533	non-cytoplasmic
534	541	cytoplasmic
542	561	transmembrane
562	564	cytoplasmic
565	565	non-cytoplasmic

Input:
>WP_028316862.1 NCBI__GCF_000429905.1:WP_028316862.1
MSIGFLAIAACVPILVALVLMVWMHWPAVRAMPMAWAVCAVLAVAVWKMPVGFVLAATLG
GFGNTLNILIIIFGAIVLLFSLQESGGMETIKQGIGGLSDDKRVQILLIAFLFSAFLEGA
AGFGTPAAIAAPLLISLGFPALAAVMACLILNSFPVTFGVIGAVVWFGLKNLTPLVNSAA
AQGIAPASIPDAWAFFGVVGKWGAVLNTLPIFILPLFVICFVTRYFGANRSWKEGLGAWK
ISLFASACFAAAYLFFAFVMGIEFPSLMGGLIALAMTVFAVKQKWLLPANTWTFGPKEQW
EKDWIGSIDMNGGGQNAANMSQMRAWAPYILIGALLMLTRLSSLPFKSWVMGLEINIPAI
MGYESVNFSMKPFYLPGIMPFMLTALLIVPMHGMSWKKAGVAWSNALKRIIGPALALMFA
VALVEIFKQSAHNALDYPSMPLSMAKGAAALAGGAWPLFASFVGALGAFITGSNTVSNLL
FSEFQYGLAEQMHLPRQIIVALQLVGGSMGNMVCIHNIVAASAVVGLTGAEGAIIKRNSV
PLLIYGLCTGLLGMLFCYVLFPGIF

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server